Zura Bio Limited
ZURA
$1.99
$0.2413.71%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 79.42% | 68.93% | 65.18% | 68.81% | 89.76% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 75.85% | 4.37% | -11.89% | -29.80% | -34.17% |
| Operating Income | -75.85% | -4.37% | 11.89% | 29.80% | 34.17% |
| Income Before Tax | -94.61% | -6.12% | 13.47% | 34.43% | 46.34% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -94.61% | -6.12% | 13.47% | 34.43% | 46.34% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -100.00% | -100.00% |
| Net Income | -94.61% | -6.12% | 13.18% | 32.61% | 44.69% |
| EBIT | -75.85% | -4.37% | 11.89% | 29.80% | 34.17% |
| EBITDA | -515.21% | -- | -- | -- | -- |
| EPS Basic | -45.51% | 56.02% | 87.51% | 99.15% | 99.31% |
| Normalized Basic EPS | -12.81% | 52.95% | 79.62% | 98.46% | 98.58% |
| EPS Diluted | -45.51% | 56.02% | 87.51% | 99.15% | 99.31% |
| Normalized Diluted EPS | -12.81% | 52.95% | 79.62% | 98.46% | 98.58% |
| Average Basic Shares Outstanding | 69.40% | 97.66% | 127.76% | 201.02% | 464.14% |
| Average Diluted Shares Outstanding | 69.40% | 97.66% | 127.76% | 201.02% | 458.54% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |